Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Shou-man Wang"'
Publikováno v:
Heliyon, Vol 9, Iss 2, Pp e13294- (2023)
Purpose: The purpose of this study was to investigate the correlation between S100 calcium binding protein A9 (S100A9), tumour glycolysis and tumour infiltrating lymphocytes (TIL) in human epidermal growth factor receptor 2 (HER2) - positive breast c
Externí odkaz:
https://doaj.org/article/d4d55f4a7b0c4f68a2c44e73069005b8
Publikováno v:
Molecular Therapy: Oncolytics, Vol 21, Iss , Pp 62-73 (2021)
Triple-negative breast cancer (TNBC) is a highly invasive subtype of breast cancer. This study investigated the molecular mechanism and influences of MIR503HG, miR-224-5p, and homeobox A9 (HOXA9) on TNBC cell growth and migration. Dual-luciferase rep
Externí odkaz:
https://doaj.org/article/0dfd7f28954547a282cae671e49cb3d9
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background As an aggressive subtype of breast cancer with a high risk of recurrence, triple-negative breast cancer (TNBC) lacks available treatment targets. LncRNA MIR100HG promotes cell proliferation in TNBC. However, few studies have inves
Externí odkaz:
https://doaj.org/article/cf016f4a6ac34a8baae0018537b993cc
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-15 (2020)
Cancer Cell International
Cancer Cell International
Background As an aggressive subtype of breast cancer with a high risk of recurrence, triple-negative breast cancer (TNBC) lacks available treatment targets. LncRNA MIR100HG promotes cell proliferation in TNBC. However, few studies have investigated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::009d7b201bbcd6d629d0dde3596a5836
http://link.springer.com/article/10.1186/s12935-020-01580-6
http://link.springer.com/article/10.1186/s12935-020-01580-6
Publikováno v:
Gland Surg
BACKGROUND: This study sought to estimate the prognostic effect of intratumoral heterogeneity (ITH) and Yes-associated protein 1 (YAP1) intensity in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients. We also investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4310d044db91c495beda438e5c72121
https://pubmed.ncbi.nlm.nih.gov/35284307
https://pubmed.ncbi.nlm.nih.gov/35284307
Autor:
Jie Tang, Lu Tang, Jun-Li Deng, Yun-Hua Xu, Guo Wang, Shou-Man Wang, Ying Huang, Hai-Bo Zhang, Li-Ping Wang
Publikováno v:
DNA and cell biology. 39(7)
Breast cancer (BC) is the most malignant tumor in women. The molecular mechanisms underlying tumorigenesis still need to be further elucidated. It is necessary to investigate novel candidate genes involved in breast cancer progression and prognosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aade099e6f655648696c9a63abab1844
https://pubmed.ncbi.nlm.nih.gov/32456464
https://pubmed.ncbi.nlm.nih.gov/32456464
Autor:
Fei-Yu Chen, Wang, Hao, Li, Hui, Hu, Xue-Li, Dai, Xu, Shou-Man Wang, Guo-Jiao Yan, Ping-Lan Jiang, Hu, Yuan-Ping, Huang, Juan, Tang, Li-Li
Supplementary_Tables for Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population by Fei-Yu Chen, Hao Wang, Hui Li, Xue-Li Hu, Xu Dai, Shou-Man Wang, Guo-J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6323da7b98f92e7c2ee56bf89144281e
Publikováno v:
Journal of cellular biochemistry. 119(1)
Chemotherapy is one of the standard strategies for treatment of breast cancer. Adriamycin (Dox) is a first-line chemotherapy agent for breast cancer. However, the gastrointestinal reactions, myocardial toxicity and other side effects caused by Dox du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e6ba34a40b8c78f380b4df112c4cb25
https://pubmed.ncbi.nlm.nih.gov/28671278
https://pubmed.ncbi.nlm.nih.gov/28671278
Publikováno v:
Therapeutics and Clinical Risk Management
Fei-Yu Chen, Hui-Ying Ou, Shou-Man Wang, Yu-Hui Wu, Guo-Jiao Yan, Li-Li Tang Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha City, Hunan Province, People's Republic of China Background: Several studies have shown a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5813a02068bfbc1d71350dfccaa1373a
https://pubmed.ncbi.nlm.nih.gov/23576872
https://pubmed.ncbi.nlm.nih.gov/23576872
Publikováno v:
Therapeutics & Clinical Risk Management; 2013, Vol. 9, p131-137, 7p